A KOREAN anti-wrinkle product has been officially launched in the Philippines, which is expected to hold at least 15 percent of the aesthetic market by end of this year.
Nabota Philippines Brand Manager Christopher Cachuela told the BusinessMirror that the country has a big potential for beauty-enhancing products given the increasing number of Filipinos who are conscious of their looks, apart from well-being.
Industry figures show that the local market for aesthetic products grows in a year by 11 percent, and this is projected to further rise as the country’s flourishing economy and strong buying power of consumers continue.
With this in mind, Daewoong Pharma Philippines has widened its drug portfolio since its inception in 2007.
“We have a lot of products for bone and wound care. That’s why last year, we expanded to skin and beauty,” he said.
From its primary focus on orthopedicsurgery and advanced wound care system, the company started its foray in dermatology with the introduction of Perfectha filler in 2014, and now in aesthetics via a botulinum toxin-type formula called Nabota.
What differentiates it from other botulinum neurotoxin brands are its purity, stability and anti-diffusion properties, according to Prof. Joonpio Hong, who presented it to local doctor-clients, such as dermatologists, plastic surgeons cosmetics surgeons and aesthetic surgeons.
He said that its high-purity product minimizes the side effect that may be caused by the diffusion into other tissues from the site of injection. Developed through Daewoong Pharmaceutical Co. Ltd.’s technology at its facility in South Korea, it can be administered through injections to enhance the frown lines and arm paralysis, according to Dr. Rosalina Nadela, the immediate past president of Philippine Dermatological Society.
It has also recently proved itself as efficacious treatment for post-stroke stiffness in upper extremity muscles in three-phase clinical trials on muscle rigidities, and expanded its application even to cosmetological and therapeutic areas.
For Dr. Maria Cristina Puyat, who is the clinical study and Nabota pioneer in the Philippines, it is safer and more effective, as well as faster in action and has a longer duration of effectivity.
She noted that the change can be seen already in around two days, and it lasts for about three to four months. For a more successful result, this botulinum toxin type A is more effective when combined with derma fillers.
“So if you want to remove the wrinkles of a patient, it’s very important to use Perfectha first [as fillers], followed by toxins [that is Nabota],” Cachuela said.
Nabota is now available in five markets globally, starting from Korea and Thailand last year, to Latin America, Middle East and the Philippines this year.
“By next year we are targeting a share of 30 percent of the local market because by 2020 we want to be the market leader globally,” he said.
To date, the major South Korean drugmaker has already made 90 contracts globally to distribute and market this product worldwide.
Daewoong Pharamceutical Co. Executive Director for Global Business Division Sengho Jeon expects Nabota to be exported in the United States and Europe once approved by the health authorities in 2017.
“It is hoped to become available in over 100 countries worldwide in the next two years,” he revealed.
2 comments
Congrats Nabota and Daewoong! Grab the lion’s share.
My derma recommended this Korean Nabota but the result was annoying. The effect lasted for 5 weeks only and injection was so painful! So much for fake botox. My original Botox of Allergan lasts for 8 months.